Tensha Therapeutics' Series A Round

Tensha Therapeutics raised a round of funding on September 12, 2011. Investors include HealthCare Ventures.

Tensha Therapeutics is a biotechnology company developing small molecule bromodomain inhibitors to regulate disease-linked gene transcription. Tensha noted that its lead preclinical program is intende…

Articles about Tensha Therapeutics' Series A Round: